These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 14123621)

  • 1. [INTERFERENCE BY D-AMPHETAMINE IN THE ACTION OF SOME MONOAMINE OXIDASE INHIBITORS].
    FERRI S; MAFFEI-FACCIOLI A; ORNESI A; SCAMAZZO T
    Boll Soc Ital Biol Sper; 1963 Nov; 39():1381-4. PubMed ID: 14123621
    [No Abstract]   [Full Text] [Related]  

  • 2. SELF-STIMULATION OF THE BRAIN AND THE CENTRAL STIMULANT ACTION OF AMPHETAMINE.
    STEIN L
    Fed Proc; 1964; 23():836-50. PubMed ID: 14195468
    [No Abstract]   [Full Text] [Related]  

  • 3. INHIBITION OF MONOAMINE OXIDASE ACTION ON KYNURAMINE BY SUBSTRATE AMINES AND STEREOISOMERIC ALPHA-METHYL AMINES.
    FULLER RW; WALTERS CP
    Biochem Pharmacol; 1965 Feb; 14():159-63. PubMed ID: 14332461
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECTS OF ENZYME INHIBITORS ON THE ADRENERGIC MECHANISMS IN ISOLATED VAS DEFERENS PREPARATION.
    BHARGAVA KP; KAR K; PARMAR SS
    Life Sci (1962); 1963 Dec; 12():989-92. PubMed ID: 14100232
    [No Abstract]   [Full Text] [Related]  

  • 5. THE CONVERSION OF PHOSPHORYLASE B TO PHOSPHORYLASE A IN BRAIN.
    BRECKENRIDGE BM; NORMAN JH
    J Neurochem; 1965 Jan; 12():51-7. PubMed ID: 14268514
    [No Abstract]   [Full Text] [Related]  

  • 6. MONOAMINE OXIDASE INHIBITORS.
    PERKS ER
    Anaesthesia; 1964 Jul; 19():376-86. PubMed ID: 14174638
    [No Abstract]   [Full Text] [Related]  

  • 7. NEW ORALLY ACTIVE MONOAMINE OXIDASE (MAO) INHIBITORS.
    JORI A; BONACCORSI A; VALZELLI L; GARATTINI S
    Life Sci (1962); 1963 Aug; 8():611-7. PubMed ID: 14058510
    [No Abstract]   [Full Text] [Related]  

  • 8. MONOAMINE OXIDASE INHIBITORS. IV. SOME DIALKYLAMINOPHENYLALKYLHYDRAZINES AND RELATED COMPOUNDS.
    FINKELSTEIN J; ROMANO JA; CHIANG E; LEE J
    J Med Chem; 1963 Mar; 6():153-5. PubMed ID: 14188787
    [No Abstract]   [Full Text] [Related]  

  • 9. MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS IN ENHANCING AMPHETAMINE TOXICITY.
    BRITTAIN RT; JACK D; SPENCER PS
    J Pharm Pharmacol; 1964 Aug; 16():565-7. PubMed ID: 14223999
    [No Abstract]   [Full Text] [Related]  

  • 10. [DERIVATIVES OF 2-PHENYLCYCLOPROPANECARBOXYLIC ACID HYDRAZIDE WITH MONOAMINE OXIDASE INHIBITING ACTION].
    CARISSIMI M; CAVALIERI E; GRUMELLI E; MULLA E; RAVENNA F
    Farmaco Sci; 1964 Oct; 19():809-21. PubMed ID: 14228403
    [No Abstract]   [Full Text] [Related]  

  • 11. EFFECTS OF RESERPINE PRE-TREATMENT ON THE PROTECTIVE ACTION OF AMPHETAMINE AND PHENOXYPROPAZINE IN THE PHENYLBENZOQUINONE-INDUCED WRITHING SYNDROME IN MICE.
    DAVIS RA; HORLINGTON M
    Nature; 1964 Jan; 201():306-7. PubMed ID: 14110466
    [No Abstract]   [Full Text] [Related]  

  • 12. [EFFECT OF ALPHA-SUBSTITUTED BETA-(2-METHYL-3-INDOLYL)-PROPIONIC ACID HYDRAZIDES ON THE ACTIVITY OF BRAIN MONOAMINO OXIDASES].
    SAFRAZBEKIAN RR; SUKASIAN RS
    Farmakol Toksikol; 1964; 27():213-7. PubMed ID: 14193091
    [No Abstract]   [Full Text] [Related]  

  • 13. A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)-amphetamine, p-methoxyamphetamine and harmaline.
    Green AL; El Hait MA
    Biochem Pharmacol; 1980 Oct; 29(20):2781-9. PubMed ID: 6893669
    [No Abstract]   [Full Text] [Related]  

  • 14. AN ANALYSIS OF THE INTERACTION OF REVERSIBLE AND IRREVERSIBLE MONOAMINE OXIDASE INHIBITORS.
    HORITA A; CHINN C
    Biochem Pharmacol; 1964 Mar; 13():371-8. PubMed ID: 14157597
    [No Abstract]   [Full Text] [Related]  

  • 15. TOXICITY AND CATECHOLAMINE RELEASING ACTIONS OF D- AND L-AMPHETAMINE IN ISOLATED AND AGGREGATED MICE.
    MOORE KE
    J Pharmacol Exp Ther; 1963 Oct; 142():6-12. PubMed ID: 14076523
    [No Abstract]   [Full Text] [Related]  

  • 16. INTERRELATIONSHIPS BETWEEN AMPHETAMINE AND HARMALA ALKALOIDS.
    SCHMITT H; SCHMITT H
    Nature; 1964 Aug; 203():877-8. PubMed ID: 14204082
    [No Abstract]   [Full Text] [Related]  

  • 17. [INHIBITION OF RAT BRAIN MONOAMINE OXIDASES BY BETA-PHENYLISOPROPYLHYDRAZINE AND HARMALINE: HISTOCHEMICAL STUDY OF THE ACTION OF THESE INHIBITORS AND THEIR ANTAGONISM].
    BOUCHAUD C; COUTEAUX R; GAUTRON J
    C R Hebd Seances Acad Sci; 1965 Jan; 260():348-51. PubMed ID: 14305447
    [No Abstract]   [Full Text] [Related]  

  • 18. TREATMENT OF DEPRESSION.
    PARE CM
    Lancet; 1965 May; 1(7392):923-5. PubMed ID: 14275707
    [No Abstract]   [Full Text] [Related]  

  • 19. THE CUMULATIVE NATURE OF THE RESERPINE EFFECT AND THE POSSIBILITIES OF INHIBITING CUMULATION PHARMACOLOGICALLY.
    KNOLL J; KNOLL B
    Arch Int Pharmacodyn Ther; 1964 Mar; 148():200-16. PubMed ID: 14171749
    [No Abstract]   [Full Text] [Related]  

  • 20. POTENTIATION OF THE ANTI-RESERPINE EFFECTS OF DIHYDROXYPHENYLALANINE BY ANTIDEPRESSANTS AND STIMULANTS.
    MCGRATH WR; KETTELER HJ
    Nature; 1963 Aug; 199():917-8. PubMed ID: 14079911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.